Carriers' Planned Cuts For Blood Glucose Test Strips Flawed - Trade Groups
This article was originally published in The Gray Sheet
The Durable Medical Equipment Regional Carriers' plan for cutting payment for blood glucose test strips is so severely flawed that it should be scrapped, according to the Health Industry Manufacturers Association and the National Association for Medical Equipment Services.
You may also be interested in...
ASTM International is proposing a new standard that will provide a cleaning agent formula for removing dried blood from stainless steel medical devices.
Executive appointments at MyoKardia, Scancell Holdings and Sutro Biopharma
The merger between Mylan and Pfizer’s Upjohn unit finally concluded on 16 November 2020, giving Viatris the go ahead for business. The newly-established company has announced receiving tentative approval for its 10mg pediatric dolutegravir tablets from the FDA under the PEPFAR program.